Načítá se...
Scientific Rigor Recommendations for Optimizing the Clinical Applicability of Translational Research
The approval of new therapies to treat neurodegenerative disease conditions by the Food and Drug administration (FDA) has been hindered by many failed clinical trials, which were based upon “significant” efficacy in preclinical or translational studies. Additional problems during drug development re...
Uloženo v:
| Hlavní autor: | |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2012
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3905455/ https://ncbi.nlm.nih.gov/pubmed/24490120 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4172/2155-9562.1000e111 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|